For example, it has been reported that miR-195 plays a positive effect on the chemotherapy sensitivity of doxorubicin in colon cancer cells by targeting the first binding site of BCL2L2 mRNA [35]. This evidence concerns the gene BCL2L2 and malignant colon neoplasm.